TechValidate Research on Clinical Flow Cytometry

11 Charts


Beckman Coulter Customer Research

Consequences of insufficient reagent quality

Additional rework or retesting
74%
Challenges in interpreting data
63%
Failed quality controls
63%
False results
48%

Beckman Coulter Customer Research

Please rate the following Beckman Coulter flow cytometry reagents compared to other suppliers.

Best in class Significantly better Better Worse

Quality, Stability, Robustness
Lot-to-Lot Consistency
Performance, e.g. Sensitivity, Background Reduction
Application & Product Support
Complete Solution including Instrument, Software & Reagents

Beckman Coulter Customer Research

What is the most important decision factor when purchasing a new antibody for flow cytometry?

Quality, Stability, Robustness
57%
Performance, e.g. Sensitivity, Background Reduction
20%
Lot-to-Lot Consistency
10%
Application & Product Support
7%
Regulatory Status
7%
Price
0%

Beckman Coulter Customer Research

If a Leukemia and Lymphoma process control with IVD/CE-IVD approval were commercially available, would you purchase it for use in your laboratory?

Yes: 76%
No: 16%
Other: 8%

Beckman Coulter Customer Research

How much validation & accreditation time would you save, when utilizing a process control that has CE-IVD/IVD status?

More than 25%: 29%
10 - 25%: 59%
0 - 10%: 12%

Beckman Coulter Customer Research

Controls in Clinical Flow Cytometry

What are the main challenges when implementing a process control for Leukemia & Lymphoma immunophenotyping?

Need to use several controls for full panel coverage
70%
No standard control
52%
Availability of CE-IVD/IVD controls
44%
Limited market offer
44%

Beckman Coulter Customer Research

Controls in Clinical Flow Cytometry

Which of these consequences could happen when not running a process control daily?

Challenges in interpreting data
66%
Repeat testing
66%
False results
59%
Additional rework
52%
Failed quality controls
48%

Beckman Coulter Customer Research

Which type of controls are you using and how would you rate them?

Best in class Significantly better Better Worse
Fresh patient or normal whole blood samples

28%

36%

36%

0%

Cryo-persevered patient or normal samples

17%

33%

22%

28%

Cell lines

0%

31%

50%

19%

Commercially available controls

13%

54%

29%

4%

Internal Positive Controls (using the expression patterns of normal cells in the sample)

41%

36%

23%

0%

Beckman Coulter Customer Research

Lab Requirements for Control Cells

What is the most important decision factor when purchasing new control cells for Flow Cytometry?

Quality, Stability, Robustness
61%
Full Panel Coverage
21%
Price
9%
Application & Product Support
3%
Process Control
3%
Regulatory Status
3%

Beckman Coulter Customer Research

Controls in Clinical Flow Cytometry

How often do you run Leukemia and Lymphoma controls in your laboratory?

Every day
45%
Once per month
30%
Once per quarter
3%

Beckman Coulter Customer Research

Leukemia and Lymphoma Cases in Clinical Flow Cytometry Labs

Number of L&L cases analyzed per week in the US

1 - 10
12%
11 - 50
45%
51 - 100
39%
Greater than 100
3%



More Research on Clinical Flow Cytometry